These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33969786)

  • 1. Circulating Long Non-Coding RNA GAS5: A Non-Invasive Molecular Marker for Prognosis, Response to Treatment and Survival in Non-Small Cell Lung Cancer.
    Al Mourgi M; El Askary A; Gharib AF; Alzahrani R; Banjer HJ; Elsawy WH; Al Ghamdi AE; Raafat N
    Cancer Invest; 2021; 39(6-7):505-513. PubMed ID: 33969786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating long noncoding RNA GAS5 is a novel biomarker for the diagnosis of nonsmall cell lung cancer.
    Liang W; Lv T; Shi X; Liu H; Zhu Q; Zeng J; Yang W; Yin J; Song Y
    Medicine (Baltimore); 2016 Sep; 95(37):e4608. PubMed ID: 27631209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of circulating long non-coding RNA GAS5 as a potential biomarker for non-small cell lung cancer diagnosisnon-small cell lung cancer, long non-coding RNA, plasma, GAS5, biomarker.
    Tan Q; Zuo J; Qiu S; Yu Y; Zhou H; Li N; Wang H; Liang C; Yu M; Tu J
    Int J Oncol; 2017 May; 50(5):1729-1738. PubMed ID: 28339045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating long non-coding RNA GAS5 and SOX2OT as potential biomarkers for diagnosis and prognosis of non-small cell lung cancer.
    Kamel LM; Atef DM; Mackawy AMH; Shalaby SM; Abdelraheim N
    Biotechnol Appl Biochem; 2019 Jul; 66(4):634-642. PubMed ID: 31077615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer.
    Xie Y; Zhang Y; Du L; Jiang X; Yan S; Duan W; Li J; Zhan Y; Wang L; Zhang S; Li S; Wang L; Xu S; Wang C
    Mol Oncol; 2018 May; 12(5):648-658. PubMed ID: 29504701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA BRCAT54 inhibits the tumorigenesis of non-small cell lung cancer by binding to RPS9 to transcriptionally regulate JAK-STAT and calcium pathway genes.
    Yang W; Qian Y; Gao K; Zheng W; Wu G; He Q; Chen Q; Song Y; Wang L; Wang Y; Gu P; Chen B; Zhai R
    Carcinogenesis; 2021 Feb; 42(1):80-92. PubMed ID: 32459848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A critical role for the long non-coding RNA GAS5 in proliferation and apoptosis in non-small-cell lung cancer.
    Shi X; Sun M; Liu H; Yao Y; Kong R; Chen F; Song Y
    Mol Carcinog; 2015 Jun; 54 Suppl 1():E1-E12. PubMed ID: 24357161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-derived exosomal lncRNA GAS5 as a biomarker for early-stage non-small-cell lung cancer diagnosis.
    Li C; Lv Y; Shao C; Chen C; Zhang T; Wei Y; Fan H; Lv T; Liu H; Song Y
    J Cell Physiol; 2019 Nov; 234(11):20721-20727. PubMed ID: 31032916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined identification of long non-coding RNA XIST and HIF1A-AS1 in serum as an effective screening for non-small cell lung cancer.
    Tantai J; Hu D; Yang Y; Geng J
    Int J Clin Exp Pathol; 2015; 8(7):7887-95. PubMed ID: 26339353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long Noncoding RNA GAS5 Suppresses Tumorigenesis by Inhibiting miR-23a Expression in Non-Small Cell Lung Cancer.
    Mei Y; Si J; Wang Y; Huang Z; Zhu H; Feng S; Wu X; Wu L
    Oncol Res; 2017 Jul; 25(6):1027-1037. PubMed ID: 28059053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of Long Noncoding RNA GAS5 Inhibits Lung Cancer Cell Proliferation and Metastasis via miR-205/PTEN Axis.
    Dong L; Li G; Li Y; Zhu Z
    Med Sci Monit; 2019 Mar; 25():2311-2319. PubMed ID: 30926767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of the long noncoding RNA GAS5-AS1 contributes to tumor metastasis in non-small cell lung cancer.
    Wu Y; Lyu H; Liu H; Shi X; Song Y; Liu B
    Sci Rep; 2016 Aug; 6():31093. PubMed ID: 27489122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long Noncoding RNA GAS5 Inhibits Tumorigenesis and Enhances Radiosensitivity by Suppressing miR-135b Expression in Non-Small Cell Lung Cancer.
    Xue Y; Ni T; Jiang Y; Li Y
    Oncol Res; 2017 Sep; 25(8):1305-1316. PubMed ID: 28117028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long intergenic noncoding RNA GAS5 reduces cisplatin-resistance in non-small cell lung cancer through the miR-217/LHPP axis.
    Yang X; Meng L; Zhong Y; Hu F; Wang L; Wang M
    Aging (Albany NY); 2021 Jan; 13(2):2864-2884. PubMed ID: 33418541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GAS5 knockdown reduces the chemo-sensitivity of non-small cell lung cancer (NSCLC) cell to cisplatin (DDP) through regulating miR-21/PTEN axis.
    Cao L; Chen J; Ou B; Liu C; Zou Y; Chen Q
    Biomed Pharmacother; 2017 Sep; 93():570-579. PubMed ID: 28686971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression.
    Dong S; Qu X; Li W; Zhong X; Li P; Yang S; Chen X; Shao M; Zhang L
    J Hematol Oncol; 2015 Apr; 8():43. PubMed ID: 25925741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion.
    Liu L; Meng T; Yang XH; Sayim P; Lei C; Jin B; Ge L; Wang HJ
    Cancer Biomark; 2018; 22(2):283-299. PubMed ID: 29630521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of long non-coding RNAs (lncRNAs) has been dysregulated in non-small cell lung cancer tissues.
    Esfandi F; Taheri M; Omrani MD; Shadmehr MB; Arsang-Jang S; Shams R; Ghafouri-Fard S
    BMC Cancer; 2019 Mar; 19(1):222. PubMed ID: 30866866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a novel linc01125 isoform in serum exosomes as a promising biomarker for NSCLC diagnosis and survival assessment.
    Xian J; Zeng Y; Chen S; Lu L; Liu L; Chen J; Rao B; Zhao Z; Liu J; Xie C; Zhu L; Zhang D; Qiu F; Lu J; Yang L
    Carcinogenesis; 2021 Jun; 42(6):831-841. PubMed ID: 33928340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating long non-coding RNA AFAP1-AS1 is a potential diagnostic biomarker for non-small cell lung cancer.
    Li W; Li N; Kang X; Shi K
    Clin Chim Acta; 2017 Dec; 475():152-156. PubMed ID: 29080690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.